AN INDICATION FOR RECOVERY FROM ROTATOR CUFF TENDINOPATHY (RCT)
Here you will find detailed information why TendoVis™ helps the recovery of Rotator Cuff Tendinopathy (RCT). Take some time to browse the sections below.
TendoVis™ has received approval for Rotator Cuff Tendinopathy. TendoVis™ is administered by a trained medical professional using antero-lateral approach to introduce the BIOCOMPATIBLE Hyaluronic Acid (STABHA™) along the injured ligament or tendon for a speedier recovery.
The main content of TendoVis™ is STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid). TendoVis™ is a registered product. Both TendoVis™ and the manufacturing process for STABHA™ are patented.
A large clinical study conducted over the period of 6 month showed the following results:
Patients with Rotator Cuff Tendinopathy have lesser pain when resting and using the shoulder up to 6 month after using TendoVis™.
Patients with Rotator Cuff Tendinopathy have an increase of the joint function up to 6 month after using TendoVis™.
Hyaluronic acid has an ancillary effect of reducing pain and limiting inflammation.
TendoVis™ containing STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid) will help reduce the pain and limit inflammation in RCT.
It is recommended that patients suffering from Rotator Cuff Tendinopathy receive 2 injections of TendoVis™, with the 2nd injection two weeks after the 1st administration.
There is no time frame for using TendoVis™ if you are suffering from Rotator Cuff Tendinopathy.
TendoVis™ introduces STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid) to the site to promote recovery. It also aids by lubricating the injury site for the realignment of the injured tissue fibres to its ideal position for increased tensile strength for a speedier and better recovery.